Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Docetaxel Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Post-approval studies (Phase 4)UnknownNCT05302336
What this trial is testing

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Second Affiliated Hospital, Zhejiang University, School of Medicine 402
Not applicableStudy completedNCT01621425
What this trial is testing

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Who this might be right for
Breast CancerMetastatic Castration-resistant Prostate Carcinoma
Radboud University Medical Center 25
Not applicableUnknownNCT03258151
What this trial is testing

Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Who this might be right for
Solid TumorsDocetaxelDrug-Related Side Effects and Adverse Reactions+2 more
Cui Yimin 2,200
Not applicableEnded earlyNCT01958580
What this trial is testing

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Who this might be right for
Stage IA Uterine SarcomaStage IB Uterine SarcomaStage IC Uterine Sarcoma+8 more
Albert Einstein College of Medicine 3
Testing effectiveness (Phase 2)UnknownNCT00004264
What this trial is testing

Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Study completedNCT02026921
What this trial is testing

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer Recurrent
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 74
Testing effectiveness (Phase 2)UnknownNCT05461261
What this trial is testing

The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Hormone Sensitive Metastatic Prostate CancerDNA Damage Repair DeficiencyChemotherapy Effect+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Early research (Phase 1)Study completedNCT00705874
What this trial is testing

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
Progen Pharmaceuticals 172
Testing effectiveness (Phase 2)Ended earlyNCT00568971
What this trial is testing

Study of Weekly DCF to Treat Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 40
Early research (Phase 1)Study completedNCT00169520
What this trial is testing

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Who this might be right for
Solid Tumor Cancer
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Large-scale testing (Phase 3)UnknownNCT01999933
What this trial is testing

Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer

Who this might be right for
Cervical CancerToxicity Due to Radiotherapy
Mei Shi 600
Not applicableStudy completedNCT01268878
What this trial is testing

Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol

Who this might be right for
Squamous Cell Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 130